Shukra Pharmaceuticals' equity shares have been successfully listed and admitted for trading on the National Stock Exchange of India Limited (NSE) Main Board under the symbol SHUKRAPHAR.

This dual-listing is a significant step for the company, aimed at enhancing share liquidity, broadening its investor base, and increasing stakeholder value.

The company's shares will also continue to be traded on BSE Limited.

The initial trading price on NSE was set using the closing price from BSE on the preceding day.